Use of prognostic markets to guide biologic therapies for rheumatoid arthritis
- PMID: 12465172
Use of prognostic markets to guide biologic therapies for rheumatoid arthritis
Comment on
-
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group.J Rheumatol. 2000 Sep;27(9):2100-9. J Rheumatol. 2000. PMID: 10990219
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical